These novel therapies, including Wegovy, Tirzepatide , and Zaxig , represent a major advancement in managing type 2 the condition and assisting with weight loss . They function by mimicking the body’s natural peptide GLP-1 , enabling to control blood glucose and decrease appetite . Every therapy